Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 18;17(4):e82524.
doi: 10.7759/cureus.82524. eCollection 2025 Apr.

Standardization of a Molecular Technique for Human Papillomavirus Genotyping in a Public-Health Service

Affiliations

Standardization of a Molecular Technique for Human Papillomavirus Genotyping in a Public-Health Service

Sulani S De Souza et al. Cureus. .

Abstract

Objective: To standardize a molecular technique for genotyping human papillomavirus (HPV) and to evaluate its distribution and relationship with vaginal cytology.

Method: Women aged 25 years or older with altered cytology were selected from three public-health hospitals and underwent HPV genotyping by molecular biology. Samples were processed, stored, and subjected to extraction and amplification. Amplification was performed for 28 HPV types (19 of high-risk and 9 types of low-risk). The frequencies of the most prevalent HPV types and those with multiple genotypes, were calculated. The association between categorical variables was analyzed using the chi-square (χ2) and Fisher's exact test. Statistical significance was set at p < 0.05.

Results: The samples were divided into two groups: 1) without previous cervical treatment (177, 55%); and 2) with previous cervical treatment (142, 45%). The frequency of positive HPV was 126 (71%) and 67 (47%), respectively. The predominant high-risk HPVs were: 16, 58, 52 and 53; HPV53, HPV68 and HPV35 were associated with multiple infection in both groups. HPV16 and multiple infections were more prevalent between group age 25-35 years (p = 0,036; p = 0,034). High-grade intraepithelial lesions were associated with HPV16 in both groups (p = 0.001; p = 0.009) and with HPV53 in group 2 (p = 0.020). Cytology classified as atypical squamous cells of undetermined significance (ASCUS) (group 1) and negative for intraepithelial lesions and malignancy (NILM) (group 2) were associated with reduction of HPV16 (74.4%; 65.4%).

Conclusion: The two groups differed in the frequency of HPV types and the chance of single and multiple infections. High-grade intraepithelial lesions were associated with HPV16 in both groups.

Keywords: high-grade squamous intraepithelial lesion (hsil); hpv genotype; human papillomavirus infection; papanicolaou test; woman health.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Human Research Ethics Committee of Escola Superior de Ciencias da Saude (ESCS) issued approval 6.510.136 (CAAE: 26454919.1.0000.5553). Research approved on March 17, 2020. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Similar articles

References

    1. Clinical significance of human papillomavirus genotyping. Choi YJ, Park JS. J Gynecol Oncol. 2016;27:0. - PMC - PubMed
    1. Ministério da Saúde - Instituto Nacional de Câncer B. Ministério da Saúde - Estimativa 2023: Incidência de Câncer no Brasil. Estimativa 2023: Incidência de Câncer no Brasil. [ Jun; 2024 ]. 2022. https://www.inca.gov.br/publicacoes/livros/estimativa-2023-incidencia-de... https://www.inca.gov.br/publicacoes/livros/estimativa-2023-incidencia-de...
    1. Secondary prevention of cervical cancer. Basu P, Mittal S, Bhadra Vale D, Chami Kharaji Y. Best Pract Res Clin Obstet Gynaecol. 2018;47:73–85. - PubMed
    1. A global strategy for elimination of cervical cancer. [ Jul; 2024 ]. 2020. https://www.paho.org/en/end-cervical-cancer https://www.paho.org/en/end-cervical-cancer
    1. Organization of cervical cancer screening with DNA-HPV testing impact on early-stage cancer detection: a population-based demonstration study in a Brazilian city. Teixeira JC, Vale DB, Campos CS, Bragança JF, Discacciati MG, Zeferino LC. Lancet Reg Health Am. 2022;5:100084. - PMC - PubMed

LinkOut - more resources